Fanc-A gene therapy (Genethon)

N/A

Report date: 2024/09/06 14:15:23

Base Information

Drug NameFanc-A gene therapy (Genethon)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vector
Mechanisms of ActionFanconi anemia group A protein stimulants
TargetsFanconi anemia group A protein
Therapy Area/IndicationsFanconi Anemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenethon
China Registration ClassN/A

Develop Information

Active CompaniesGenethon
Inactive CompaniesN/A
Active IndicationsFanconi Anemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A